CDC Panel Backs mRNA COVID Vaccines Over J & J Due to Clot Risk CDC Panel Backs mRNA COVID Vaccines Over J & J Due to Clot Risk
The panel cited the rare but potentially fatal cases of thrombosis with thrombocytopenia syndrome that can arise after the J&J vaccine.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news
More News: Cancer & Oncology | Hematology | Infectious Diseases | Thrombocytopenia | Thrombosis | Vaccines